Oramed Pharmaceuticals Inc.

ORMP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
8/31/2021
Assets
Cash & Equivalents$54,420$9,055$40,464$77,245
Short-Term Investments$87,510$152,992$115,256$16,895
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,291$537$1,389$1,197
Total Curr. Assets$143,221$162,584$157,109$95,337
Property Plant & Equip (Net)$1,112$1,567$1,809$932
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$10,911$56,366$2,700$6,692
Tax Assets$0$0$0$0
Other NC Assets$34$34$24$25,038
Total NC Assets$12,057$57,967$4,533$32,662
Other Assets$0$0$0$0
Total Assets$155,278$220,551$161,642$127,999
Liabilities
Payables$789$551$2,175$2,606
Short-Term Debt$216$51,280$247$130
Tax Payable$3,204$0$0$0
Deferred Revenue$0$0$1,340$2,703
Other Curr. Liab.$1,476$1,383-$191-$1,366
Total Curr. Liab.$5,685$53,214$5,746$6,679
LT Debt$156$342$647$403
Deferred Rev, NC$4,000$4,000$4,000$4,244
Deferred Tax Liab, NC$0$0$11$11
Other NC Liab.$90$102$82$145
Total NC Liab.$4,246$4,444$4,740$4,803
Other Liabilities$0$0$0$0
Cap. Leases$372$609$0$0
Total Liabilities$9,931$57,658$10,486$11,482
Equity
Pref Stock$0$0$0$0
Common Stock$480$485$476$424
Retained Earnings-$176,616-$157,556-$163,081-$114,852
AOCI$0$0$0$0
Other Equity$644,802$320,892$314,417$230,201
Total Equity$146,265$163,821$151,812$115,773
Supplemental Information
Minority Interest-$918-$928-$656$744
Total Liab. & Tot. Equity$155,278$220,551$161,642$127,999
Net Debt-$54,048$42,567-$39,570-$76,712
Oramed Pharmaceuticals Inc. (ORMP) Financial Statements & Key Stats | AlphaPilot